Progressive anemia following combination therapy with interferon-α and interleukin-2 in a patient with metastatic renal cell carcinoma

被引：0
|
作者：
Hosokawa, Y
Kishino, T
Ono, T
Oyama, N
Hayashi, K
Momose, H
机构：
[1] Hoshigaoka Koseinenkin Hosp, Dept Urol, Osaka 5738511, Japan
[2] Hoshigaoka Koseinenkin Hosp, Dept Hematol, Osaka 5738511, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2004年 / 11卷 / 10期
关键词：
autoimmunity; hemolytic anemia; interleukin-2;
D O I：
10.1111/j.1442-2042.2004.00914.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Various toxicities have been observed during the treatment of advanced renal cell carcinoma with interferon-alpha (IFN-alpha) and/or interleukin-2 (IL-2). We report a case of severe anemia, which responded well to steroid therapy, in a patient receiving IL-2 plus IFN-alpha for metastatic renal cell carcinoma.
引用
收藏
页码：906 / 908
页数：3
相关论文
共 50 条
  • [1] Monotherapy with interferon-α, or combination therapy with interferon-α, interleukin-2 and 5-fluorouracil for metastatic renal cell carcinoma
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 285 - 285
  • [2] Interleukin-2, interferon-α and medroxyprogesterone acetate in metastatic renal cell carcinoma
    Naglieri, E
    Lopez, M
    Lelli, G
    Morelli, F
    Amodio, A
    Di Tonno, P
    Gebbia, N
    Di Seri, M
    Chetri, MC
    Rizzo, P
    Abbate, I
    Casamassima, A
    Selvaggi, FP
    Colucci, G
    ANTICANCER RESEARCH, 2002, 22 (05) : 3045 - 3051
  • [3] COMBINATION OF INTERLEUKIN-2 AND GAMMA-INTERFERON IN METASTATIC RENAL-CELL CARCINOMA
    ESCUDIER, B
    FARACE, F
    ANGEVIN, E
    TRIEBEL, F
    ANTOUN, S
    LECLERCQ, B
    BRANDELY, M
    ABOUDARAM, A
    NITENBERG, G
    HERCEND, T
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 724 - 728
  • [4] Successful Outcomes Using Combination Therapy of Interleukin-2 and Interferon-α for Renal Cell Carcinoma Patients with Lung Metastasis
    Akaza, Hideyuki
    Kawai, Koji
    Tsukamoto, Taiji
    Fujioka, Tomoaki
    Tomita, Yoshihiko
    Kitamura, Tadaichi
    Ozono, Seiichiro
    Miki, Tsuneharu
    Naito, Seiji
    Zembutsu, Hitoshi
    Nakamura, Yusuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (07) : 684 - 689
  • [5] Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma.: A randomized phase II trial
    Boccardo, F
    Rubagotti, A
    Canobbio, L
    Galligioni, E
    Sorio, R
    Lucenti, A
    Cognetti, F
    Ruggeri, E
    Landonio, G
    Baiocchi, C
    Besana, C
    Citterio, G
    De Rosa, M
    Calabresi, F
    TUMORI, 1998, 84 (05) : 534 - 539
  • [6] Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma:: a multicenter phase II study
    van Herpen, CML
    Jansen, RLH
    Kruit, WHJ
    Hoekman, K
    Groenewegen, G
    Osanto, S
    De Mulder, PHM
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 772 - 776
  • [7] Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma: A multicenter phase II study
    Van Herpen C.M.L.
    Jansen R.L.H.
    Kruit W.H.J.
    Hoekman K.
    Groenewegen G.
    Osanto S.
    De Mulder P.H.M.
    British Journal of Cancer, 2000, 82 (4) : 772 - 776
  • [8] Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma
    Tatsugami, Katsunori
    Eto, Masatoshi
    Harano, Masahiko
    Hamaguchi, Masumitsu
    Miyamoto, Toshihiro
    Morisaki, Takashi
    Furue, Masutaka
    Akashi, Koichi
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (08) : 694 - 698
  • [9] COMBINATION BIOLOGIC THERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA IN THE OUTPATIENT TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    FIGLIN, RA
    PIERCE, WC
    BELLDEGRUN, A
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 11 - 15
  • [10] Subcutaneous interleukin-2 and interferon-α in metastatic renal cell carcinoma -: Results of a French regional experience in Languedoc
    Culine, S
    Iborra, F
    Mottet, N
    Avancès, C
    de Graeve, B
    Volpé, P
    Vignoud, J
    Bringer, JP
    Marroncle, M
    Le Pellec, L
    Ayuso, D
    Jansen, E
    Faix, A
    Rebillard, X
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 148 - 152
12345